Pliant Therapeutics to Participate in Upcoming Investor Events
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following September investor events. 2024 Wells Fargo Healthcare Conference Keith Cummings, M.D., Pliant's Chief Financial Officer, and Éric Lefebvre, M.D., Pliant's Chief Medical Officer, will participate in a fireside chat ...